United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68071-3532_44e6726a-ca3d-d488-e063-6294a90a3a33
- Product NDC
- 68071-3532
- Form
- CAPSULE
- Composition / generic term
- Cephalexin
- Labeler
- NuCare Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20051116
- Source listing expiry
- 20261231
Source-listed ingredients
- CEPHALEXIN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 21 CAPSULE in 1 BOTTLE (68071-3532-1) · 68071-3532-1
- 20 CAPSULE in 1 BOTTLE (68071-3532-2) · 68071-3532-2
- 30 CAPSULE in 1 BOTTLE (68071-3532-3) · 68071-3532-3
- 14 CAPSULE in 1 BOTTLE (68071-3532-4) · 68071-3532-4
- 60 CAPSULE in 1 BOTTLE (68071-3532-6) · 68071-3532-6
- 40 CAPSULE in 1 BOTTLE (68071-3532-7) · 68071-3532-7
- 28 CAPSULE in 1 BOTTLE (68071-3532-8) · 68071-3532-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →